الوسم: pancreatic cancer

  • Key Factors That Can Lead to Pancreatic Cancer

    Pancreatic cancer risk factors
    Credit: Unsplash+

    Pancreatic cancer ranks among the most challenging cancers to treat because it often develops without noticeable symptoms in its early stages.

    This cancer originates in the pancreas, a small organ located behind the stomach, responsible for aiding digestion and regulating blood sugar levels.

    Initially, many individuals experience minimal or no symptoms. By the time signs such as unexplained weight loss, abdominal or back pain, jaundice, or loss of appetite emerge, the cancer may have already spread beyond the pancreas.

    Over years, researchers have aimed to identify who is most at risk. A 2023 systematic review and meta-analysis in the Archives of Iranian Medicine highlighted significant links between pancreatic cancer and factors like smoking, diabetes, family history, and chronic pancreatitis.

    Smoking remains one of the most clearly preventable risks. The 2023 study revealed that smokers face a notably higher chance of developing this cancer, further supported by earlier research showing tobacco smoke can damage genetic material within cells.

    Age is another key factor—unfortunately, it cannot be altered. Pancreatic cancer becomes more common in older adults due to accumulated cellular damage over time, allowing harmful changes to develop.

    Having a family member who has had pancreatic cancer raises the risk, especially if multiple relatives are affected. A family history of the disease indicates a higher likelihood of developing it oneself.

    Genetic mutations also play a role. Variations in genes like BRCA1 and BRCA2, commonly associated with breast and ovarian cancers, have been linked to increased pancreatic cancer risk.

    Chronic inflammation of the pancreas, known as chronic pancreatitis, is another important risk factor. Repeated inflammation can damage pancreatic tissue over time, creating a setting conducive to cancer development.

    Diabetes is closely connected to pancreatic cancer. The 2023 review found elevated risk among individuals with diabetes, though the relationship can be complex—sometimes, pancreatic cancer can lead to new-onset diabetes or impact blood sugar control.

    Obesity and lifestyle choices influence risk as well. Being overweight has been associated with a higher chance of developing pancreatic cancer, while staying active and maintaining a healthy weight can help support overall health and reduce the risk of various diseases.

    Dietary habits might also contribute, although research findings are mixed. Studies have examined red and processed meats, sugary foods, fruits, vegetables, and overall dietary patterns, but definitive links require further investigation.

    Workplace exposure to certain chemicals, like pesticides, metals, or industrial substances, has been studied for potential risk. While there’s some evidence suggesting increased risk, research is ongoing to determine how much these exposures directly contribute to pancreatic cancer.

    It’s important to remember that not all cases can be prevented, and possessing one risk factor doesn’t guarantee disease development. However, avoiding tobacco, maintaining a healthy weight, staying physically active, managing diabetes effectively, and limiting heavy alcohol consumption are practical steps toward better health.

    Individuals with a strong family history or known genetic mutations related to cancer should consider discussing their risks with healthcare providers or genetic counselors. In some cases, proactive monitoring may help detect pancreatic changes earlier.

    Scientists are actively working on developing blood tests, imaging scans, and other screening tools to identify pancreatic cancer before symptoms appear. Early detection is critical since surgical intervention offers the best chance for long-term survival when the cancer is confined to the pancreas.

    Better understanding of risk factors allows researchers to identify those who might benefit from closer surveillance. Ongoing studies aim to improve prevention strategies, enable earlier diagnosis, and develop more effective treatments for this elusive disease.

    If you’re interested in cancer research, consider exploring studies linking artificial sweeteners to increased cancer risk or how milk consumption impacts heart disease and cancer risks.

    For additional health insights, check recent research on optimal vitamin intake timing for heart health and how vitamin D supplements significantly decrease cancer mortality.

    Copyright © 2026 Knowridge Science Report. All rights reserved.

  • Does Fish Oil or Olive Oil Promote Pancreatic Cancer?

    Does Fish Oil or Olive Oil Promote Pancreatic Cancer?

    Credit: Unsplash+

    When it comes to healthy eating, fat can often feel like a confusing subject. For many years, health experts emphasized minimizing overall fat consumption without much distinction between types of fats.

    More recently, the focus shifted toward choosing healthier fats rather than just cutting back on total fat. Olive oil, with its link to heart health and the Mediterranean diet, became a standout example of this approach.

    Now, new research suggests that the relationship between dietary fats and cancer might be more complex than previously thought.

    A recent study published in Cancer Discovery indicates that some dietary fats could potentially promote pancreatic cancer growth, while others might slow it down. These findings highlight that the ratio of different fats in your diet could play a role in how cancer develops.

    The study centered on pancreatic ductal adenocarcinoma, the most common form of pancreatic cancer, which is often diagnosed late and is notoriously difficult to treat. Scientists are eager to uncover lifestyle factors that could help lower the risk.

    Earlier studies suggested that diets high in fat might increase the likelihood of developing pancreatic cancer, but those studies often used unrealistic lab diets with extremely high amounts of a single fat source. Because of this, they couldn’t determine which types of fats were actually responsible for the observed effects.

    To address this, the Yale research team designed multiple diets that closely resembled real-world eating habits. Each diet provided the same number of calories, allowing researchers to focus solely on differences in fat types.

    The results revealed a notable pattern: mice fed diets high in oleic acid experienced faster tumor growth. Oleic acid is a monounsaturated fat commonly found in olive oil, high-oleic sunflower oil, safflower oil, peanuts, and other foods.

    Conversely, mice eating diets rich in polyunsaturated fats showed slower cancer progression. The most significant protective effects were observed with omega-3 fatty acids, prevalent in fish oil and fatty fish such as salmon, sardines, and mackerel.

    Further analysis uncovered the biological reasons behind these differences. It turned out that cancer cells react differently depending on the type of fat incorporated into their membranes.

    Polyunsaturated fats made cancer cells more vulnerable to a natural process that promotes the death of damaged cells, which is a crucial defense against unchecked tumor growth. Monounsaturated fats, on the other hand, seemed to shield cancer cells, enabling them to survive and multiply.

    The researchers observed a direct link between disease severity and the ratio of monounsaturated to polyunsaturated fats. As the proportion of monounsaturated fats increased relative to polyunsaturated fats, tumor growth intensified. When dietary fats shifted in favor of polyunsaturated fats, cancer development slowed.

    An intriguing aspect of the study involved differences between males and females. The cancer-promoting effects of oleic acid were mainly seen in male mice; female mice exhibited a much weaker response. This finding adds to the growing recognition that sex-specific biological differences can influence cancer risk and treatment responses.

    The study raises significant questions about cancer prevention strategies. Many patients ask healthcare providers if changing their diets could lower their cancer risk. Unfortunately, definitive answers are hard to come by because nutrition research is complex and often yields mixed results.

    While these findings don’t translate immediately into specific dietary guidelines for humans, they offer valuable insights. Future strategies for cancer prevention might focus on optimizing the balance of different types of fats rather than simply cutting overall fat intake.

    Researchers are also investigating whether blood levels of certain fatty acids could serve as early indicators of pancreatic cancer risk. If proven effective, this could help identify high-risk individuals before symptoms appear.

    It’s important to note that people shouldn’t overinterpret these results. Olive oil continues to be associated with numerous health benefits, particularly for cardiovascular health. This study was conducted in mice, and human research is necessary before making any specific recommendations.

    A key strength of this study is its meticulous design. By maintaining consistent calorie levels and only varying the type of fat, the researchers could isolate the effects of specific fatty acids. These findings suggest plausible biological mechanisms through which dietary fats influence cancer development.

    However, since the research was done in mice, it doesn’t definitively prove that the same effects occur in humans. Further human studies are essential. Even so, this research underscores the growing importance of understanding not just how much fat people consume but what types of fats are in their diets.

    If you’re interested in cancer risk factors, it’s worth looking into studies linking artificial sweeteners with higher cancer risks, or how drinking milk may influence heart disease and certain cancers.

    For additional health insights, explore recent research on the best times to take vitamins for heart health and how vitamin D supplements can significantly decrease cancer mortality.

    Source: Yale School of Medicine.


  • New Hope: Hidden Weakness in Pancreatic Cancer Uncovered

    New Hope: Hidden Weakness in Pancreatic Cancer Uncovered

    Credit: Unsplash+

    Pancreatic cancer is one of the most aggressive and hardest types of cancer to treat. It often develops quietly, with minimal symptoms in its early stages.

    By the time it’s diagnosed, the disease has usually already spread, complicating treatment options. As a result, survival rates remain low, and researchers continue searching for more effective therapies.

    Recently, scientists from The Wistar Institute, in collaboration with ChristianaCare researchers, made a significant breakthrough. Their study, published in the Proceedings of the National Academy of Sciences, uncovered a hidden vulnerability within pancreatic cancer cells. This vulnerability could become a promising target for future treatments.

    Understanding this discovery involves a bit of cellular biology. Inside every cell are small structures called mitochondria, often referred to as the cell’s “power plants” because they generate energy. In healthy cells, mitochondria are well-structured and shielded by a sturdy outer membrane.

    In many cancer cells, however, the mitochondria are damaged. The researchers found that in pancreatic cancer, these mitochondria lack a crucial structural protein named Mic60. Without Mic60, the mitochondria become unstable and start to break down.

    Instead of functioning normally, these compromised mitochondria leak materials into the cell, including double-stranded RNA. Normally, this type of RNA signals viral infection, prompting the cell to treat it as a threat.

    This detection triggers a potent immune response involving two key molecules — TLR3 and TRAF6. These act like sensors, recognizing the leaked RNA and activating inflammation inside the cell.

    While inflammation generally helps the body defend against infections and repair tissues, cancer cells hijack this process to support their growth and spread. The inflammation creates an environment conducive to tumor progression.

    Even more unexpectedly, the researchers found that over time, cancer cells become increasingly dependent on this inflammation. They rely on it not just to grow, but for survival. This suggests that disrupting this inflammatory pathway could be a way to kill the cancer cells.

    To test this, scientists used drugs to inhibit the TLR3 and TRAF6 pathway. When this route was blocked, cancer cells died, while normal cells largely remained unaffected. Animal studies further confirmed that blocking this pathway halted tumor growth.

    This discovery opens up a new approach to cancer treatment. Instead of aiming to directly kill cancer cells, therapies could focus on cutting off their critical survival signals, potentially reducing side effects and increasing effectiveness.

    Nevertheless, caution is needed when interpreting these results. Most research has been conducted in lab settings and animal models. Additional studies are essential to verify if this approach will be effective and safe in humans. Developing drugs that precisely inhibit this pathway remains a priority.

    Despite these challenges, the findings are encouraging. Pancreatic cancer is notorious for limited treatment options, and identifying a new target offers fresh hope and direction for future research.

    In the coming years, scientists aim to better understand how the absence of Mic60 damages mitochondria and triggers this inflammatory process. They also plan to develop safe drugs that can inhibit the TLR3/TRAF6 pathway in patients.

    In summary, this research reveals a potential weakness in pancreatic cancer—linked to inflammation caused by damaged mitochondria. While more work is necessary, these insights provide new hope for developing better, targeted therapies against this challenging disease.

    If you’re interested in cancer prevention, consider reading about how a low-carb diet could increase overall cancer risk, as well as berries that may help prevent cancer, diabetes, and obesity.

    For additional health insights, explore recent studies on the effects of milk consumption on heart disease and cancer risks, and findings that vitamin D supplements might significantly reduce cancer mortality.

    Source: The Wistar Institute.

  • New Drug Offers Hope for Longer Pancreatic Cancer Survival

    New Drug Offers Hope for Longer Pancreatic Cancer Survival

    Credit: Unsplash+

    Pancreatic cancer is notoriously difficult to treat and has one of the lowest survival rates among all cancers. Many patients are diagnosed at advanced stages when the disease has already spread, making effective treatment challenging. For years, medical professionals have been searching for better options to help extend patient lives.

    Recent research from Northwestern Medicine, published in *Nature Medicine*, offers some promising developments. Scientists tested a new drug called elraglusib to determine if it could enhance survival rates when combined with standard chemotherapy.

    The study involved over 200 patients with advanced pancreatic cancer, who were randomly assigned to two groups. One group received the typical chemotherapy treatment, while the other received chemotherapy plus the experimental drug.

    The findings were encouraging. Patients treated with elraglusib lived longer than those who only received chemotherapy, with survival times extending by several months on average. For many, this additional time can be invaluable, allowing for more moments with loved ones.

    Additionally, the likelihood of surviving at least one year was significantly higher in the group receiving the new drug. Nearly half of these patients were still alive after a year, compared to about 20% in the standard treatment group. Some even reached two years of survival, which is uncommon for this cancer type.

    This drug is unique because it doesn’t attack cancer cells directly. Instead, it targets a protein in the body that promotes tumor growth and helps cancer evade the immune system. Blocking this protein could help the immune system better recognize and fight the tumor.

    Further analysis suggested that elraglusib might boost the number of immune cells within tumors, indicating it may help “activate” the immune system’s natural defenses against cancer.

    Like many cancer therapies, elraglusib can cause side effects such as fatigue and alterations in blood cell counts. However, medical teams reported these side effects were generally manageable.

    While these results are promising, experts emphasize this is just an initial step. Larger, more comprehensive studies are necessary to confirm the findings and ensure the drug’s safety for broader use. Researchers are also exploring potential combinations of this drug with other emerging treatments.

    Overall, this study demonstrates that innovative approaches in cancer therapy can make a meaningful difference, even with formidable diseases like pancreatic cancer. Though not a cure, it offers hope for improved outcomes and underscores the importance of ongoing research to build on these strides.

    If you’re interested in cancer-related topics, consider looking into studies suggesting that a low-carb diet could increase overall cancer risk or explore berries’ role in preventing cancer, diabetes, and obesity.

    For additional health insights, check out recent research on how drinking milk influences heart disease and cancer risks, along with findings indicating that vitamin D supplements might significantly lower cancer mortality.

    Source: Northwestern University.

  • Judge Frank Caprio’s Final Days Battling Cancer

    Judge Frank Caprio’s Final Days Battling Cancer

    Digital Phablet – Judge Frank Caprio spent his final days courageously battling pancreatic cancer.

    Judge Frank Caprio, popularly known worldwide as “America’s nicest judge,” has passed away at the age of 88. He died on August 20, 2025, after a prolonged battle with pancreatic cancer.

    Caprio served as the chief judge of Rhode Island’s Providence Municipal Court for many years. He chose to step down from his judicial position in 2023 after serving since 1985. His compassionate approach gained him fame through the popular TV show Caught in Providence, which showcased real courtroom cases from 2018 to 2020. Clips from this show have been viewed over a billion times worldwide.

    Judge Caprio was known for his genuine concern for others. He often handled minor traffic violations with kindness and humor. Rather than solely punishing, he listened to people’s stories and showed empathy. He frequently reduced or canceled fines when he recognized hardships. “I don’t wear a badge under my robe; I wear a heart,” he once said. This reflected his belief that justice should be rooted in understanding.

    John Caprio was born in Rhode Island in 1936. His parents emigrated from Italy. As a young boy, he picked up odd jobs such as delivering newspapers and shining shoes. Later, he attended Providence College and Suffolk University to become a lawyer. Throughout his journey, he also served as an educator and was part of the Rhode Island Army National Guard.


    Judge Frank Caprio’s Instagram profile

    In December 2023, he revealed his diagnosis of pancreatic cancer. His final message, made the day before his passing, asked everyone to keep him in their prayers.

    People worldwide shared their memories and tributes after his death. Rhode Island Governor Dan McKee called him "a Rhode Island treasure." His family described him as a wonderful friend, husband, father, and grandfather.

    Judge Caprio left behind a legacy of kindness, fairness, and compassion. He proved that justice can be achieved through empathy and understanding. His work and life impacted many, inspiring others to treat everyone with dignity and care, and his influence will continue to motivate for generations.

  • Judge Frank Caprio, ‘Caught in Providence’ Star, Passes at 88

    Judge Frank Caprio, ‘Caught in Providence’ Star, Passes at 88

    Frank Caprio, who served as the long-time Chief Judge of Providence Municipal Court and gained popularity as the star of the reality TV show Caught in Providence, has passed away at age 88 after a prolonged battle with pancreatic cancer, his family has announced.

    He died peacefully on Wednesday, August 20.

    “Judge Frank Caprio left us peacefully at 88 after fighting pancreatic cancer with courage,” his family expressed in a Facebook statement. “In his memory, let’s all aim to add a bit more kindness to the world — just as he did every single day.”

    Rhode Island Governor Dan McKee ordered flags at state offices and buildings to fly at half-staff until Caprio’s funeral.

    “Judge Caprio was a true Rhode Island treasure,” McKee stated. “On a personal note, he was a friend who confronted his illness bravely, and I will deeply miss him. My sympathies are with his family and loved ones during this difficult time.”

    “Judge Caprio not only served the public diligently but also connected with people in a heartfelt way. He demonstrated what justice with compassion can look like,” he added.

    A Judge Known Worldwide

    Caprio gained international recognition through Caught in Providence, a long-running reality TV series that showcased his kindhearted approach to minor traffic violations. His blend of humor and empathy often brought smiles and comfort to those appearing in his courtroom.

    The show aired locally for over 20 years before reaching viewers nationwide. Clips of his rulings became popular on YouTube, with new videos still appearing long after he retired from the bench.

    “I don’t wear a badge beneath my robe,” Caprio often said. “I wear a heart.”

    Earlier this year, he published his memoir titled Compassion in the Court: Life-Changing Stories from America’s Nicest Judge.

    His Illness and Final Months

    In December 2023, Caprio disclosed his diagnosis of pancreatic cancer. He lauded his medical team in Boston and Providence, though he acknowledged facing “an insidious form of cancer.”

    He kept his 1.7 million followers on Instagram updated, sometimes sharing videos during chemotherapy treatments. In one clip, he listened to singer-songwriter Jewel, who later said she was “honored to provide some comfort” during his treatment.

    Frank Caprio is remembered both in Rhode Island and beyond as a compassionate man who brought kindness to the courtroom.